Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruedy

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
JAMA|February 10, 1989
Cessation of zidovudine therapy may lead to increased replication of HIV-1M A Wainberg, J Falutz, M Fanning, et al.
Diabetes Technology & Therapeutics|September 29, 2022
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 DiabetesRoy W Beck, Steven J Russell, Edward R Damiano, et al.
AIDS (London, England)|February 1, 1993
Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT TrialJ S Montaner, J Singer, M T Schechter, et al.
Diabetes Technology & Therapeutics|March 2, 2005
Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) studyMichael J Tansey, Roy W Beck, Bruce A Buckingham, et al.
Diabetologia|March 17, 2015
CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetesBruce Buckingham, Peiyao Cheng, Roy W Beck, et al.
AIDS (London, England)|April 1, 1995
Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complexM A Wainberg, H Salomon, Z Gu, et al.
Diabetes Care|August 14, 2009
Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes, Bruce Bode, Roy W Beck, et al.
Pediatric Diabetes|August 16, 2013
Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosisEda Cengiz, Crystal G Connor, Katrina J Ruedy, et al.
Canadian Medical Association Journal|September 22, 1979
Antihypertensive efficacy of propranolol given twice dailyS M MacLeod, P Hamet, H Kaplan, et al.
Diabetes Technology & Therapeutics|February 9, 2011
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoringDongyuan Xing, Craig Kollman, Roy W Beck, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
JAMA|February 10, 1989
Cessation of zidovudine therapy may lead to increased replication of HIV-1M A Wainberg, J Falutz, M Fanning, et al.
Diabetes Technology & Therapeutics|September 29, 2022
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 DiabetesRoy W Beck, Steven J Russell, Edward R Damiano, et al.
AIDS (London, England)|February 1, 1993
Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT TrialJ S Montaner, J Singer, M T Schechter, et al.
Diabetes Technology & Therapeutics|March 2, 2005
Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) studyMichael J Tansey, Roy W Beck, Bruce A Buckingham, et al.
Diabetologia|March 17, 2015
CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetesBruce Buckingham, Peiyao Cheng, Roy W Beck, et al.
AIDS (London, England)|April 1, 1995
Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complexM A Wainberg, H Salomon, Z Gu, et al.
Diabetes Care|August 14, 2009
Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes, Bruce Bode, Roy W Beck, et al.
Pediatric Diabetes|August 16, 2013
Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosisEda Cengiz, Crystal G Connor, Katrina J Ruedy, et al.
Canadian Medical Association Journal|September 22, 1979
Antihypertensive efficacy of propranolol given twice dailyS M MacLeod, P Hamet, H Kaplan, et al.
Diabetes Technology & Therapeutics|February 9, 2011
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoringDongyuan Xing, Craig Kollman, Roy W Beck, et al.
Pageof 15